A detailed history of Israel Englander (Millennium Management LLC) transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 219,464 shares of PTCT stock, worth $9.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
219,464
Previous 317,579 30.89%
Holding current value
$9.41 Million
Previous $9.71 Million 16.16%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.39 - $37.66 $2.98 Million - $3.7 Million
-98,115 Reduced 30.89%
219,464 $8.14 Million
Q2 2024

Aug 14, 2024

BUY
$24.69 - $40.12 $4.33 Million - $7.03 Million
175,289 Added 123.19%
317,579 $9.71 Million
Q1 2024

May 15, 2024

SELL
$24.15 - $31.95 $8.89 Million - $11.8 Million
-368,286 Reduced 72.13%
142,290 $4.14 Million
Q4 2023

Feb 14, 2024

BUY
$18.07 - $29.37 $9.1 Million - $14.8 Million
503,715 Added 7341.71%
510,576 $14.1 Million
Q2 2023

Aug 14, 2023

BUY
$40.4 - $59.1 $277,184 - $405,485
6,861 New
6,861 $279,000
Q4 2022

Feb 14, 2023

SELL
$33.53 - $54.79 $4.77 Million - $7.79 Million
-142,220 Reduced 32.22%
299,133 $11.4 Million
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $18.5 Million - $23.8 Million
441,353 New
441,353 $22.2 Million
Q1 2022

May 16, 2022

SELL
$33.33 - $44.6 $861,713 - $1.15 Million
-25,854 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$35.36 - $41.86 $474,460 - $561,677
13,418 Added 107.9%
25,854 $1.03 Million
Q3 2021

Nov 15, 2021

BUY
$37.01 - $44.74 $249,262 - $301,323
6,735 Added 118.14%
12,436 $463,000
Q2 2021

Aug 16, 2021

SELL
$37.95 - $49.37 $5.51 Million - $7.16 Million
-145,077 Reduced 96.22%
5,701 $241,000
Q1 2021

May 17, 2021

BUY
$46.8 - $68.92 $6.33 Million - $9.33 Million
135,331 Added 876.1%
150,778 $7.14 Million
Q4 2020

Feb 16, 2021

BUY
$47.96 - $67.64 $740,838 - $1.04 Million
15,447 New
15,447 $943,000
Q2 2020

Aug 14, 2020

SELL
$42.56 - $54.98 $1.69 Million - $2.18 Million
-39,682 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$32.37 - $59.36 $1.3 Million - $2.38 Million
-40,159 Reduced 50.3%
39,682 $1.77 Million
Q4 2019

Feb 14, 2020

SELL
$32.22 - $50.07 $3.84 Million - $5.96 Million
-119,038 Reduced 59.85%
79,841 $3.84 Million
Q3 2019

Nov 14, 2019

SELL
$33.82 - $48.17 $35 Million - $49.8 Million
-1,034,449 Reduced 83.87%
198,879 $6.73 Million
Q2 2019

Aug 15, 2019

BUY
$35.42 - $45.0 $41.5 Million - $52.8 Million
1,172,800 Added 1937.62%
1,233,328 $55.5 Million
Q2 2019

Aug 14, 2019

SELL
$35.42 - $45.0 $16.9 Million - $21.5 Million
-477,473 Reduced 88.75%
60,528 $10.4 Million
Q1 2019

May 14, 2019

BUY
$28.09 - $39.49 $10.5 Million - $14.8 Million
374,690 Added 229.43%
538,001 $20.3 Million
Q4 2018

Feb 14, 2019

SELL
$29.83 - $46.51 $5.5 Million - $8.58 Million
-184,434 Reduced 53.04%
163,311 $5.61 Million
Q3 2018

Nov 14, 2018

SELL
$33.9 - $47.77 $2.58 Million - $3.64 Million
-76,161 Reduced 17.97%
347,745 $16.3 Million
Q2 2018

Aug 14, 2018

SELL
$25.7 - $47.88 $6.52 Million - $12.1 Million
-253,595 Reduced 37.43%
423,906 $14.3 Million
Q1 2018

May 15, 2018

BUY
$17.46 - $32.59 $2.14 Million - $3.99 Million
122,296 Added 22.03%
677,501 $18.3 Million
Q4 2017

Feb 14, 2018

BUY
$15.14 - $20.89 $4.46 Million - $6.15 Million
294,572 Added 113.02%
555,205 $9.26 Million
Q3 2017

Nov 14, 2017

BUY
$16.81 - $21.61 $4.38 Million - $5.63 Million
260,633
260,633 $5.22 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.07B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.